Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.

European Patent Office grants new CRISPR/Cas9 patent (EP 4 289 948 ... targets for therapeutic intervention; development of cell lines for drug discovery and screening; bioproduction of antibodies ...

The fourth industrial revolution marked by the fusion of technologies is blurring the lines between ... the two cell-based gene therapies approved by the FDA, utilise the CRISPR/Cas9 genome ...

Technology Networks caught up with Professor Mazhar Adli to learn more about his research on the characterization of ...

Ryotaro Hashizume and colleagues use the CRISPR-Cas9 gene editing system to cleave the third chromosome in previously generated trisomy 21 cell lines derived from both pluripotent cells and skin ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...